Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase

American Journal of Physiology - Gastrointestinal and Liver Physiology - Tập 309 Số 10 - Trang G841-G854 - 2015
Stephen D. Zucker1, Megan Vogel1, Tammy L. Kindel1, David S. Askew1, Gila Idelman1, Uri Avissar1, Ganesh V. Kakarlapudi1, Michelle E. Masnovi1
1Division of Digestive Diseases, University of Cincinnati, Cincinnati, Ohio

Tóm tắt

Bilirubin is thought to exert anti-inflammatory effects by inhibiting vascular cell adhesion molecule-1 (VCAM-1)-dependent leukocyte migration and by suppressing the expression of inducible nitric oxide synthase (iNOS). As VCAM-1 and iNOS are important mediators of tissue injury in the dextran sodium sulfate (DSS) murine model of inflammatory colitis, we examined whether bilirubin prevents colonic injury in DSS-treated mice. Male C57BL/6 mice were administered 2.5% DSS in the drinking water for 7 days, while simultaneously receiving intraperitoneal injections of bilirubin (30 mg/kg) or potassium phosphate vehicle. Disease activity was monitored, peripheral blood counts and serum nitrate levels were determined, and intestinal specimens were analyzed for histological injury, leukocyte infiltration, and iNOS expression. The effect of bilirubin on IL-5 production by HSB-2 cells and on Jurkat cell transendothelial migration also was determined. DSS-treated mice that simultaneously received bilirubin lost less body weight, had lower serum nitrate levels, and exhibited reduced disease severity than vehicle-treated animals. Concordantly, histopathological analyses revealed that bilirubin-treated mice manifested significantly less colonic injury, including reduced infiltration of eosinophils, lymphocytes, and monocytes, and diminished iNOS expression. Bilirubin administration also was associated with decreased eosinophil and monocyte infiltration into the small intestine, with a corresponding increase in peripheral blood eosinophilia. Bilirubin prevented Jurkat migration but did not alter IL-5 production. In conclusion, bilirubin prevents DSS-induced colitis by inhibiting the migration of leukocytes across the vascular endothelium and by suppressing iNOS expression.

Từ khóa


Tài liệu tham khảo

10.4049/jimmunol.181.10.7390

10.1002/ibd.20753

10.1073/pnas.252626999

10.1053/j.gastro.2007.01.032

10.1152/ajpgi.00309.2003

10.1111/j.1365-3024.2007.01017.x

10.1097/01.MIB.0000164017.06538.8a

10.1056/NEJM199511023331802

10.1165/ajrcmb.12.3.7873190

10.1053/gast.2001.29568

10.1097/00004836-200302000-00006

10.1006/bbrc.1996.1087

10.1152/ajplung.1997.272.2.L219

10.1172/JCI116941

10.1042/bj20030794

Cooper HS, 1993, Lab Invest, 69, 238

10.1097/00054725-200305000-00006

10.1016/j.dld.2005.03.013

Davis J, 2007, J Vis Exp, 3, 183

10.1016/j.crohns.2011.11.010

Discombe G, 1946, Lipids, 247, 195

10.4049/jimmunol.172.9.5664

10.2741/4111

10.1093/cvr/cvv147

10.1056/NEJMoa020732

10.1172/JCI119045

10.1007/s00384-006-0236-0

10.7326/0003-4819-7-10-1278

10.1001/archinte.1938.00020030081006

10.1016/S0891-5849(01)00565-2

10.1093/carcin/bgn211

10.1161/01.ATV.0000148405.18071.6a

10.4049/jimmunol.174.6.3709

Kita H, 2011, Immunol Res, 242, 161

Kitani A, 1998, J Immunol, 161, 4931, 10.4049/jimmunol.161.9.4931

10.2353/ajpath.2007.060594

10.1084/jem.194.9.1207

10.1172/JCI200215256

10.1096/fj.04-2368fje

10.1016/S0165-5728(03)00132-2

10.1172/JCI0214097

10.1152/ajpgi.1998.274.3.G544

10.4049/jimmunol.164.12.6550

10.1016/0378-1119(95)00112-J

10.1038/84915

10.1042/bj1290797

10.1177/0192623308329342

Mobley JL, 1994, Blood, 83, 1039, 10.1182/blood.V83.4.1039.1039

10.1016/S0360-3016(03)00523-6

10.1084/jem.179.4.1145

10.1046/j.1365-2249.1999.00878.x

10.1016/0016-5085(90)90290-H

10.1189/jlb.1205734

10.1002/(SICI)1097-0215(19990730)82:3<385::AID-IJC12>3.0.CO;2-5

Rachmilewitz D, 1998, Am J Gastroenterol, 93, 409

10.1136/gut.51.4.529

10.1165/ajrcmb.17.2.2819

10.1034/j.1600-065X.2001.790114.x

10.1126/science.2876520

10.1056/NEJMoa043335

10.1056/NEJM193401252100404

10.1016/S0016-5085(96)70055-0

10.1093/carcin/bgq050

10.4049/jimmunol.172.6.3553

10.1038/labinvest.3780164

10.1126/science.3029864

Tanaka T, 2005, Carcinogenesis, 26, 229, 10.1093/carcin/bgh292

10.1001/archinte.1938.00020030111007

10.1093/intimm/dxh284

10.1046/j.1365-2362.2003.01214.x

10.1053/j.gastro.2006.12.027

10.1111/j.1600-065X.1998.tb01198.x

10.1111/j.1398-9995.2007.01510.x

10.1002/hep.20334

10.1016/j.bpg.2007.12.001

10.1084/jem.177.2.561

10.1152/ajpheart.1999.276.6.H2044

10.1046/j.1365-2036.2000.014s1026.x

Yue G, 2001, J Pharmacol Exp Ther, 297, 915

Thông tin
Thông tin xuất bản

American Journal of Physiology - Gastrointestinal and Liver Physiology

Tập 309 Số 10

G841-G854

Thông tin tác giả